Clinical Trials

Showing 1 - 3 of 3 clinical trials matching your search

NCT05987241

MODERN: An Integrated Phase 2/3 and Phase 3 Trial of MRD-Based Optimization of ADjuvant ThErapy in URothelial CaNcer A032103

This study is currently enrolling.

Associated Conditions: Genitourinary

Research Area: Clinical Cancer Research

Research Location: Orlando

This study is being done to answer the following question: After having your bladder surgically removed after being diagnosed with bladder cancer, can we better identify which patients need an...
NCT05929235

A Phase 1, First-in-Human, Dose-Escalation and Expansion Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial Carcinoma

This study is currently enrolling.

Associated Conditions: Multitherapeutic

Research Area: Clinical Cancer Research

Research Location: Celebration
NCT06305767

A Phase 2, Randomized, Double-blind Study of Adjuvant V940 (mRNA-4157) + Pembrolizumab (MK-3475) vs. Placebo + Pembrolizumab for High-Risk Muscle-Invasive Urothelial Carcinoma (MIUC) Post-Radical Resection

This study is currently enrolling.

Associated Conditions: Genitourinary

Research Area: Clinical Cancer Research

Research Location: Orlando

To compare V940 plus pembrolizumab to placebo plus pembrolizumab with respect to DFS. Hypothesis (H1): V940 plus pembrolizumab is superior to placebo plus pembrolizumab with respect to DFS as assessed...